People

Meg Alexander

President and chief executive officer of Ovid Therapeutics, appointed CEO effective January 1, 2026 after serving as president and chief operating officer. Joined Ovid in 2021 and led its operations and strategic transformation. Previously built a reputation and risk management business at Syneos Health.